Michelle Monje's guest appearances

Michelle Monje

The Future of Everything presented by Stanford Engineering

Stanford Radio

ChildX: Child and Maternal Health

Tony Oro

Dennis Wall

Paul Wise

Euan Ashley

Debbie Senesky

Allison Okamura

Marshall Burke

Pat Brown

Megan Palmer

Andrew Grotto

Mehran Sahami

Steven Collins

Michael Bernstein

Alex Stamos

Sam Wineburg

OwlTail

Brain cancers are known to be elusive and clever killers, but Michelle Monje, associate professor of neurology and neurological sciences, is helping to find new treatments through a better understanding of how healthy brain cells develop and how cancers often hijack those very same processes in order to grow themselves. Monje says that the last decade has seen tremendous progress in our understanding of how cancers thrive and in the development of new drugs and therapies to kill the killers. Unfortunately, many chemotherapy drugs powerful enough to kill cancers also cause lasting impairment of the patient’s cognitive abilities, a condition known among doctors and patients as “chemobrain.” Monje is on the hunt for more effective and safer treatments for brain cancer. One exciting development, she says, is a quickly evolving field known as immunotherapy, which harnesses the body’s own immune system to recognize and to kill cancers. She’s also exploring a new drug that can help specific brain cells, known as glia, counteract the harmful effects of chemobrain. Join host Russ Altman and brain cancer expert Michelle Monje for an inspiring look at new and safer treatments for brain cancer. You can listen to the Future of Everything on Sirius XM Insight Channel 121, iTunes, SoundCloud and Stanford Engineering Magazine.

Brain cancers are known to be elusive and clever killers, but Michelle Monje, associate professor of neurology and neurological sciences, is helping to find new treatments through a better understanding of how healthy brain cells develop and how cancers often hijack those very same processes in order to grow themselves. Monje says that the last decade has seen tremendous progress in our understanding of how cancers thrive and in the development of new drugs and therapies to kill the killers. Unfortunately, many chemotherapy drugs powerful enough to kill cancers also cause lasting impairment of the patient’s cognitive abilities, a condition known among doctors and patients as “chemobrain.” Monje is on the hunt for more effective and safer treatments for brain cancer. One exciting development, she says, is a quickly evolving field known as immunotherapy, which harnesses the body’s own immune system to recognize and to kill cancers. She’s also exploring a new drug that can help specific brain cells, known as glia, counteract the harmful effects of chemobrain. Join host Russ Altman and brain cancer expert Michelle Monje for an inspiring look at new and safer treatments for brain cancer. You can listen to the Future of Everything on Sirius XM Insight Channel 121, iTunes, SoundCloud and Stanford Engineering Magazine.

Michelle Monje: New therapies for brain cancer

The Future of Everything with Russ Altman:"Michelle Monje: New therapies for brain cancer"A deepening understanding of how the healthy brain grows and functions is leading to exciting new brain cancer therapies that are both more effective and easier on patients.Brain cancers are known to be elusive and clever killers, but Michelle Monje, associate professor of neurology and neurological sciences, is helping to find new treatments through a better understanding of how healthy brain cells develop and how cancers often hijack those very same processes in order to grow themselves.Monje says that the last decade has seen tremendous progress in our understanding of how cancers thrive and in the development of new drugs and therapies to kill the killers. Unfortunately, many chemotherapy drugs powerful enough to kill cancers also cause lasting impairment of the patient’s cognitive abilities, a condition known among doctors and patients as “chemobrain.”Monje is on the hunt for more effective and safer treatments for brain cancer. One exciting development, she says, is a quickly evolving field known as immunotherapy, which harnesses the body’s own immune system to recognize and to kill cancers. She’s also exploring a new drug that can help specific brain cells, known as glia, counteract the harmful effects of chemobrain.Originally aired on SiriusXM on March 23, 2019.Recorded at Stanford Video.

The Future of Everything with Russ Altman: "Michelle Monje: New therapies for brain cancer" A deepening understanding of how the healthy brain grows and functions is leading to exciting new brain cancer therapies that are both more effective and easier on patients. Brain cancers are known to be elusive and clever killers, but Michelle Monje, associate professor of neurology and neurological sciences, is helping to find new treatments through a better understanding of how healthy brain cells develop and how cancers often hijack those very same processes in order to grow themselves. Monje says that the last decade has seen tremendous progress in our understanding of how cancers thrive and in the development of new drugs and therapies to kill the killers. Unfortunately, many chemotherapy drugs powerful enough to kill cancers also cause lasting impairment of the patient’s cognitive abilities, a condition known among doctors and patients as “chemobrain.” Monje is on the hunt for more effective and safer treatments for brain cancer. One exciting development, she says, is a quickly evolving field known as immunotherapy, which harnesses the body’s own immune system to recognize and to kill cancers. She’s also exploring a new drug that can help specific brain cells, known as glia, counteract the harmful effects of chemobrain. Originally aired on SiriusXM on March 23, 2019. Recorded at Stanford Video.

E74 | Michelle Monje: New therapies for brain cancer

Michelle Monje, MD, discusses pediatric neuro-oncology at the Childx 2015. Childx is a dynamic, TED-style conference designed to inspire innovation in pediatric and maternal health. The inaugural conference took place from April 2-3, 2015. Learn more: http://childx.stanford.edu/

Michelle Monje, MD, discusses pediatric neuro-oncology at the Childx 2015. Childx is a dynamic, TED-style conference designed to inspire innovation in pediatric and maternal health. The inaugural conference took place from April 2-3, 2015. Learn more: <a href="http://childx.stanford.edu/" rel="nofollow" target="_blank">http://childx.stanford.edu/</a>

Michelle Monje, MD: Stanford Childx Conference 